COMMD1 (68) functioned as an anti-cancer agent in lung cancer, whereas COMMD4 (18), COMMD8 (19), and COMMD9 (20) increased the growth of lung cancer cells. This evidence concerns the gene COMMD9 and lung carcinoma.